Cencora, Inc. $COR Shares Sold by NewEdge Wealth LLC

NewEdge Wealth LLC cut its stake in shares of Cencora, Inc. (NYSE:COR) by 55.8% during the first quarter, Holdings Channel reports. The firm owned 2,193 shares of the company’s stock after selling 2,766 shares during the quarter. NewEdge Wealth LLC’s holdings in Cencora were worth $689,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Kemnay Advisory Services Inc. acquired a new position in shares of Cencora in the 4th quarter valued at $25,000. Oakworth Capital Inc. acquired a new stake in Cencora during the 4th quarter worth about $26,000. Elyxium Wealth LLC acquired a new stake in Cencora during the 4th quarter worth about $27,000. Archer Investment Corp raised its holdings in Cencora by 134.3% during the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares during the period. Finally, Motiv8 Investments LLC purchased a new stake in Cencora during the fourth quarter valued at about $29,000. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Cencora news, Director Lauren M. Tyler acquired 550 shares of Cencora stock in a transaction that occurred on Monday, June 22nd. The stock was acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the purchase, the director owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on COR. Bank of America raised their target price on shares of Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Robert W. Baird reduced their price target on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating for the company in a research report on Thursday, May 7th. William Blair began coverage on shares of Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating for the company. Citigroup lowered their price objective on shares of Cencora from $405.00 to $355.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, Morgan Stanley set a $342.00 target price on shares of Cencora in a research note on Friday, May 8th. Eleven research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Cencora has an average rating of “Moderate Buy” and a consensus target price of $367.75.

Cencora Trading Up 2.9%

NYSE:COR opened at $320.05 on Wednesday. The company has a market capitalization of $62.27 billion, a P/E ratio of 24.54, a P/E/G ratio of 1.73 and a beta of 0.58. The stock’s 50 day moving average price is $286.59 and its 200 day moving average price is $315.90. The company has a debt-to-equity ratio of 3.40, a quick ratio of 0.59 and a current ratio of 0.95. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). The business had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. Cencora had a net margin of 0.78% and a return on equity of 135.20%. Cencora’s revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the firm earned $4.42 earnings per share. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, research analysts forecast that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora announced that its Board of Directors has authorized a share repurchase program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to buy up to 3.9% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Cencora Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were issued a dividend of $0.60 per share. The ex-dividend date was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.